My watch list  

Registration Manager (m/f) – Part-time 50%

Advertisement No. 206761BR
More about Sandoz
  • Job Offers

    Associate Scientist Formulation Development (m/f)

    Come and work with us as Associate Scientist Formulation Development (m/f) Biologics Technical Development & Manufacturing, Sandoz GmbH, Schaftenau Areas of Responsibility Design, plan, perform, interpret and report experiments for the formulation development of biopharmaceutical pipeline ... more

    Lab Head Analytical Development (m/f)

    Come and work with us as Lab Head Analytical Development (m/f) Area of Responsibility Leading an analytical team of 5 to 10 associates: resource planning, Instrument qualification, experimentation and method development, data handling and data management for the analysis and development o ... more

    Scientist Drug Product Analytical Development (m/f)

    Come and work with us as Scientist Drug Product Analytical Development (m/f) Areas of Responsibility Support developmental projects as protein analytical expert Compile analytical reports and regulatory documents Act as partner for Drug Product Development (i.e. liquid or lyo in syringe o ... more

  • News

    Sandoz to invest $80 million in Boucherville facilities

    Sandoz Canada announced that it will invest $80 million in its Boucherville facilities as demand for its generic sterile injectable pharmaceuticals continues to grow in Canada and around the world. In addition to more than 100 new positions created in 2006, 100 additional jobs will be creat ... more

    PLIVA Acquires Uso Racional in Spain

    PLIVA d.d. announced that an agreement has been signed with Novartis' generics division, Sandoz, for the purchase of its Spanish subsidiary Uso Racional S.L (UR) for a total cash consideration of EUR 21.5m. With expected sales of about EUR 12m in 2006, UR represents a well known and establi ... more

    Lek enhances its competitiveness with a new plant in Lendava

    Lek, a Sandoz company, opened a new plant at its Lendava site for the final phases of isolation of potassium clavulanate, which is the key ingredient of Amoksiklav, one of Lek's leading products that ranks among leading products also in Sandoz. Regular production of potassium clavulanate be ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE